Adipotide Peptide, also known as FTPP peptide, fat-targeted proapoptotic peptide, or proapoptotic peptide, has been widely researched, and is considered by scientists to be a proapoptotic peptide that may contribute to cell apoptosis. Adipotide may possibly act as a prohibitin-targeting peptide, and current research is still exploring its potential in this area . Prohibitins are natural proteins considered by scientists to regulate such functions as cell formation, metabolism, and inflammation.
Adipotide was initially considered by research teams for its supposed potential in mitigating the action of cancer cells, but the peptide indicated potential during laboratory analysis in lyposis and obesity-mitigation, leaving the research pioneers “at a loss of words.” It was presumed that Adipotide might prevent blood supply to the carcinogenic cells, resulting in carcinogenic cell death and growth inhibition. Upon further research, it was suggested by the scientists that the peptide appeared to exhibit the same mechanism of action, but on fat cells instead. Finding this interesting, the researchers called the study a “proof of concept,” adding that the peptide would have to be studied further to understand its full potential and impact on cells.
-------------------------------------